Cumberland Pharmaceuticals (CPIX) Change in Inventory (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Change in Inventory of -$703861.0 for Q1 2026, up 27.24% on a YoY basis from -$553167.6 in Q1 2025, and down 441.7% sequentially from $205989.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Change in Inventory (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Change in Inventory data on file, last reported at -$703861.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 27.24% year-over-year to -$703861.0; the trailing twelve-month figure through Mar 2026 stood at -$2.0 million (up 38.26% YoY), and the FY2025 full-year result was -$2.2 million, up 6.88% from the prior year.
- Change in Inventory eased to -$703861.0 in Q1 2026, from $205989.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.6 million in Q3 2022 to a low of -$2.3 million in Q1 2022.
- A 5-year average of -$367224.1 and a median of -$630409.0 in 2025 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory surged 756.09% in 2022 and tumbled 1073.11% in 2024, its largest moves.
- Tracing CPIX's Change in Inventory over 5 years: stood at $427803.0 in 2022, then climbed by 3.2% to $441498.0 in 2023, then plunged by 402.63% to -$1.3 million in 2024, then jumped by 115.42% to $205989.0 in 2025, then sank by 441.7% to -$703861.0 in 2026.
- Business Quant data shows CPIX's Change in Inventory at -$703861.0 in Q1 2026, $205989.0 in Q4 2025, and -$630409.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -703,861.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -703,861.00 |
| Mar 31, 2026 | -703,861.00 |
| Dec 31, 2025 | 205,989.00 |
| Dec 31, 2025 | 205,989.00 |
| Sep 30, 2025 | -630,409.00 |
| Sep 30, 2025 | -630,409.00 |
| Jun 30, 2025 | -850,797.00 |
| Jun 30, 2025 | -850,797.00 |
| Mar 31, 2025 | -967,399.00 |
| Mar 31, 2025 | -967,399.00 |
| Dec 31, 2024 | -1.34 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | 170,950.00 |
| Sep 30, 2024 | 170,950.00 |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | -170,469.00 |
| Mar 31, 2024 | -170,469.00 |
| Dec 31, 2023 | 441,498.00 |
| Dec 31, 2023 | 441,498.00 |